Janssen Biotech
-
Merck Launches Renflexis, a Biosimilar Version of Remicade
Merck has launched a biosimilar version of Remicade, Johnson & Johnson’s blockbuster drug, writes John George for Philadelphia Business Journal.…
-
Janssen Biotech Enters Licensing Agreement with California’s Protagonist Therapeutics
Horsham’s Janssen Biotech has entered into a global licensing and collaboration agreement with California’s Protagonist Therapeutics, writes John George for…
-
Scandal Star Helps Janssen Biotech Raise Psoriasis Awareness
Horsham’s Janssen Biotech has partnered with the National Psoriasis Foundation to launch ‘Psoriasis: The Inside Story,’ a campaign that puts…
Founding Partners
Advertisement
Affiliate Partners
Community Partners
